ANDE vs. XENE
ANDE (The Andersons, Inc.) and XENE (Xenon Pharmaceuticals Inc.) are both stocks. ANDE operates in Food Distribution (Consumer Defensive), while XENE operates in Biotechnology (Healthcare). Over the past 10 years, ANDE returned 9.88%/yr vs 24.15%/yr for XENE. At a 0.13 correlation, their price movements are largely independent.
Performance
ANDE vs. XENE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ANDE achieves a 34.15% return, which is significantly higher than XENE's 22.24% return. Over the past 10 years, ANDE has underperformed XENE with an annualized return of 9.88%, while XENE has yielded a comparatively higher 24.15% annualized return.
ANDE
- 1D
- -0.51%
- 1M
- 0.01%
- YTD
- 34.15%
- 6M
- 30.40%
- 1Y
- 95.81%
- 3Y*
- 18.01%
- 5Y*
- 20.61%
- 10Y*
- 9.88%
XENE
- 1D
- 3.55%
- 1M
- 1.14%
- YTD
- 22.24%
- 6M
- 18.90%
- 1Y
- 70.95%
- 3Y*
- 11.05%
- 5Y*
- 24.94%
- 10Y*
- 24.15%
ANDE vs. XENE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ANDE The Andersons, Inc. | 34.15% | 33.82% | -28.80% | 67.00% | -7.77% | 61.48% | 0.81% | -13.20% | -2.10% | -29.00% |
XENE Xenon Pharmaceuticals Inc. | 22.24% | 14.34% | -14.89% | 16.81% | 26.22% | 103.12% | 17.32% | 107.77% | 123.36% | -63.31% |
Correlation
The correlation between ANDE and XENE is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Nov 5, 2014 | 0.13 |
The correlation between ANDE and XENE shifts across timeframes, from 0.01 (1 year) to 0.17 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ANDE:
$5.02
XENE:
-$4.72
ANDE:
$10.98B
XENE:
$0.00
ANDE:
$754.24M
XENE:
-$78.30M
ANDE:
$272.26M
XENE:
-$399.62M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ANDE vs. XENE — Risk / Return Rank
ANDE
XENE
ANDE vs. XENE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Andersons, Inc. (ANDE) and Xenon Pharmaceuticals Inc. (XENE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ANDE | XENE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.63 | ||
| Sortino ratioReturn per unit of downside risk | +0.07 | ||
| Omega ratioGain probability vs. loss probability | 1.46 | 1.35 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 6.84 | 3.88 | +2.96 |
| Martin ratioReturn relative to average drawdown | 19.43 | 8.65 | +10.79 |
Loading charts...
Drawdowns
ANDE vs. XENE - Drawdown Comparison
The maximum ANDE drawdown since its inception was -81.75%, smaller than the maximum XENE drawdown of -90.43%. Use the drawdown chart below to compare losses from any high point for ANDE and XENE.
Loading charts...
Drawdown Indicators
| ANDE | XENE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.75% | -90.43% | +8.68% |
Max Drawdown (1Y)Largest decline over 1 year | -14.09% | -18.40% | +4.31% |
Max Drawdown (3Y)Largest decline over 3 years | -46.94% | -43.59% | -3.35% |
Max Drawdown (5Y)Largest decline over 5 years | -48.82% | -43.59% | -5.23% |
Max Drawdown (10Y)Largest decline over 10 years | -72.72% | -77.66% | +4.94% |
Current DrawdownCurrent decline from peak | -10.78% | -12.70% | +1.92% |
Average DrawdownAverage peak-to-trough decline | -32.29% | -39.42% | +7.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.95% | 8.23% | -3.28% |
Volatility
ANDE vs. XENE - Volatility Comparison
The Andersons, Inc. (ANDE) has a higher volatility of 8.87% compared to Xenon Pharmaceuticals Inc. (XENE) at 8.27%. This indicates that ANDE's price experiences larger fluctuations and is considered to be riskier than XENE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ANDE | XENE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.87% | 8.27% | +0.60% |
Volatility (6M)Calculated over the trailing 6-month period | 25.13% | 46.47% | -21.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.18% | 59.90% | -25.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.88% | 67.60% | -28.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.55% | 66.41% | -24.86% |
Dividends
ANDE vs. XENE - Dividend Comparison
ANDE's dividend yield for the trailing twelve months is around 1.11%, while XENE has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ANDE The Andersons, Inc. | 1.11% | 1.47% | 1.41% | 1.29% | 2.07% | 1.82% | 2.86% | 2.71% | 2.22% | 2.07% | 1.40% | 1.82% |
XENE Xenon Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ANDE vs. XENE - Financials Comparison
This section allows you to compare key financial metrics between The Andersons, Inc. and Xenon Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ANDE and XENE have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANDE has higher volatility (8.87%) compared to XENE (8.27%). In terms of maximum drawdown, ANDE dropped -81.75% vs XENE's -90.43%.
ANDE currently has the higher Sharpe Ratio (2.82 vs 1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ANDE and XENE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer